science
Washington — FDA Warns of Herpes ‘Remedies’ Sold on Amazon, Walmart

Products marketed online as herpes "remedies" and sold through Amazon and Walmart's marketplace platforms pose a public health risk, the Food and Drug Administration has said, according to a report by U.S. News & World Report. The report did not specify the names of the individual products, the number of listings involved, or the exact wording of the agency's notice, and those details were not independently verifiable from the material reviewed for this story.
What did the FDA say about herpes remedies sold on Amazon and Walmart?
According to the U.S. News & World Report account, the FDA identified herpes treatment products listed on Amazon and Walmart's online marketplaces as a public health concern. The report characterized the agency's position as a warning rather than a recall, consistent with how FDA typically handles concerns about products sold by third-party sellers on large e-commerce platforms. Neither Amazon nor Walmart's response, if any, was detailed in the available reporting, and no specific enforcement action — such as a warning letter, import alert, or product seizure — was cited.
Why would unapproved herpes products be flagged as a public health risk?
FDA warnings about unapproved treatments for sexually transmitted infections generally center on a narrow set of concerns: products that claim to cure, treat, or suppress herpes simplex virus without having gone through the agency's drug-approval process, which requires clinical evidence of safety and effectiveness. When such products reach consumers through open online marketplaces rather than pharmacies, regulators have said the risk is less about the substance itself and more about the claim attached to it — a consumer who believes a product will treat or cure an outbreak may delay seeking care from a licensed clinician. The specific reasoning cited in this case was not detailed in the sourced report.
Is there an FDA-approved treatment for herpes?
No FDA-approved cure for herpes simplex virus exists. The agency has approved a small number of prescription antiviral medications — acyclovir, valacyclovir, and famciclovir — for managing outbreaks and reducing transmission risk, but these drugs suppress symptoms rather than eliminate the virus. Any product marketed as a "cure" or a one-time "remedy" for herpes falls outside that approved category, which is the general basis the agency has used in prior actions against similarly marketed sexual-health products, though the exact legal basis cited in this specific case was not included in the available reporting.
What should someone who bought one of these products do?
Consumers who purchased a product marketed as a herpes remedy or cure through an online marketplace are typically advised, in line with standard FDA consumer guidance, to stop use, consult a licensed health care provider before making any treatment decisions, and report adverse effects or suspect products through the FDA's MedWatch reporting system. Buyers can also flag listings directly to the retailer where the product was purchased. The sourced report did not list a specific product name, lot number, or seller to search for, which limits the ability to identify an exact match to the products referenced in the FDA warning.
What happens next with FDA enforcement?
What to watch
- Whether the FDA issues a formal warning letter or import alert naming specific products or sellers
- Whether Amazon or Walmart removes or restricts flagged listings from their marketplaces
- Whether additional retailers or product categories are named as the story develops
- Whether the FDA publishes consumer guidance specific to herpes-related marketplace products
HTT News Science Desk will update this report if the FDA publishes a formal notice, warning letter, or additional product-specific detail, or if Amazon and Walmart issue statements on the listings referenced in the original report.
How does FDA typically coordinate with online marketplaces on flagged listings?
The U.S. News & World Report account did not describe any direct communication between the FDA and Amazon or Walmart regarding the herpes products in question. In prior cases involving unapproved health products sold through third-party marketplace listings, the FDA has generally relied on public warnings, warning letters to named sellers, or referrals to the Federal Trade Commission rather than ordering platforms to remove listings outright, since marketplace operators are not themselves the manufacturers of record. Whether that pattern applies here was not addressed in the sourced report, and neither Amazon nor Walmart was quoted or cited as having commented on the specific listings described.